Pharmasyntez took part in the XXXIII “New Technologies in Diagnostics and Treatment of Gynecologic Diseases” International Congress that was held on the online platform of the National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V. I. Kulakov. Nearly 13 thousand people attended this event. 

The experts from Russia and 11 other countries presented their latest developments in high-tech medical care in Gynecology. Among other international experts, Mikhail Shurygin, Chief R&D Officer of Pharmasyntez, presented his report on abdominal adhesions and clinical trial results on the innovative drug Seroguard® (INN: Adezmapimod).

In his welcoming speech, Mikhail Murashko, the Minister of Health of the Russian Federation, said: “I am pleased to note not only the development of surgical techniques, that due to the use of new energy and visualisationhave certainly achieved a high level, but also the appearance of new drugs, as well as new methods of diagnostics including new laboratory methods of diagnostics. The last few months allowed us to gain vast experience in launching new products for medical care to the market. We practically reformed certain quality control and product safety processes. This is a true success of the Russian medical science and industry”.